Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular Disease
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (8) , 1465-1471
- https://doi.org/10.1161/01.atv.0000081635.96290.d3
Abstract
Objective— The effects of paraoxonase (PON1) activity and of genetic variation in the PON1 promoter and coding region on carotid artery disease (CAAD) were investigated. Methods and Results— We identified functional promoter polymorphisms and examined their effects in a cohort with and without CAAD. We used the full sequences in 23 white subjects to determine the linkage disequilibrium (LD) structure of the PON1 region and to direct the grouping of haplotypes for disease association testing. There are several discrete regions of the PON1 gene with strong local LD, but the useful levels of LD do not extend across the entire gene. Indeed, PON1−162/−108/55/192 haplotype did not predict additional variation in PON1 activities compared with the 4 genotypes separately. PON1 hydrolysis activity predicted CAAD status, but this was not attributable to the promoter or coding region polymorphisms or haplotype or to the effects of smoking or statin use on PON1 activity. Conclusions— PON1 does not have LD across the g...Keywords
This publication has 41 references indexed in Scilit:
- Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 statusPharmacogenetics, 2003
- The Structure of Haplotype Blocks in the Human GenomeScience, 2002
- Haplotype Variation and Linkage Disequilibrium in 313 Human GenesScience, 2001
- Linkage Disequilibrium in Humans: Models and DataAmerican Journal of Human Genetics, 2001
- A New Statistical Method for Haplotype Reconstruction from Population DataAmerican Journal of Human Genetics, 2001
- Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxonBritish Journal of Pharmacology, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- Paraoxonase gene polymorphism in Japanese subjects with coronary heart diseaseInternational Journal of Cardiology, 1996
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993